VC firm
AVANT BIO
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, United States
- Assets under management
- $56.3MForm ADV private fund GAV, as of 2026-03-31Source (opens in a new tab)
- Latest fund size
- $57.5MSEC amount sold, as of 2024-12-23Source (opens in a new tab)
- Funds
- 1
- Legal name
- Avant Bio LLC
- avant.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Portfolio page (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
AVANT BIO is dedicated to fueling innovative companies in the Life Sciences and Healthtech space that are developing Therapeutic-Enabling Technologies capable of making therapies more accessible and unlocking new possibilities.
Investment approach
- Thesis
- Tomorrow’s cures rely on today’s Therapeutic Enabling TechnologiesSource (opens in a new tab)
- Leads rounds
- Yes
Funds
- Avant Bio Fund II LP
- $57.5MVintage 2023, Main fund, SEC amount sold
SEC registration
- Registered adviser
- AVANT BIO LLC
- CRD number
- 327673 (opens in a new tab)
- SEC file number
- 802-128768
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $56.3Mas of 2026-03-31
- Private funds reported
- 1
- Principal office
- NEW YORK, NY, United States
Locations
- Headquarters
- New York, United States
Loading relationship preview